AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12859466 — intervention group
Group type: COMPARATOR
Intervention: Saline 1 ml.kg‐1 (group S)
Number of subjects: 40
Study 11040906 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% prilocaine
Number of subjects: 125
Study 11040906 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine
Number of subjects: 125
Study 8969724 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued penicillin prophylaxis
Number of subjects: 0
Study 8969724 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 1292762 — intervention group
Group type: COMPARATOR
Intervention: Retinoids or carotenoids
Number of subjects: 0
Study 1292762 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group or placebo control group
Number of subjects: 0
Study 6209900 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclosorb cream
Number of subjects: 60
Study 6209900 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline tablets (500 mg daily)
Number of subjects: 60
Study 29459665 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant, ondansetron, and dexamethasone
Number of subjects: 40
Study 29459665 — intervention group
Group type: COMPARATOR
Intervention: Placebo, ondansetron, and dexamethasone
Number of subjects: 40
Study 28165347 — intervention group
Group type: EXPERIMENTAL
Intervention: Google Glass group
Number of subjects: 42
Study 28165347 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 42
Study 26629812 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic follow-up by general practitioners (GPs) with written guidelines, consultations within one week after discharge, and regular consultations for six months.
Number of subjects: 176
Study 26629812 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 176
Study 26629812 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic follow-up by GPs.
Number of subjects: 176
Study 23158787 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication Skills Training (CST)
Number of subjects: 56
Study 23158787 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CST)
Number of subjects: 56
Study 23158787 — intervention group
Group type: EXPERIMENTAL
Intervention: CST
Number of subjects: 56
Study 21401662 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) therapy
Number of subjects: 22
Study 21401662 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy
Number of subjects: 22
Study 18954649 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 80
Study 18954649 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary artery bypass grafting
Number of subjects: 80
Study 18954649 — intervention group
Group type: EXPERIMENTAL
Intervention: Arachidonic acid-induced platelet aggregation in off-pump group
Number of subjects: 80
Study 18954649 — intervention group
Group type: COMPARATOR
Intervention: Arachidonic acid-induced platelet aggregation in on-pump group
Number of subjects: 80
Study 16549220 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg Corosolic acid (CRA)
Number of subjects: 31
Study 16549220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 14666739 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest SpinBrush Pro
Number of subjects: 40
Study 14666739 — intervention group
Group type: COMPARATOR
Intervention: Oral-B CrossAction Power
Number of subjects: 40
Study 10870149 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpedicular fixation during posterolateral fusion (n = 37)
Number of subjects: 77
Study 10870149 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral fusion without transpedicular fixation (n = 40)
Number of subjects: 77
Study 8839728 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral exhaled NO in asthmatic children
Number of subjects: 47
Study 8839728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal exhaled NO in asthmatic children
Number of subjects: 47
Study 8839728 — intervention group
Group type: COMPARATOR
Intervention: Oral exhaled NO in healthy controls
Number of subjects: 47
Study 8839728 — intervention group
Group type: COMPARATOR
Intervention: Nasal exhaled NO in healthy controls
Number of subjects: 47
Study 8839728 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between oral exhaled NO and FeV1
Number of subjects: 47
Study 8839728 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between oral/nasal exhaled NO and other markers
Number of subjects: 47
Study 1538504 — intervention group
Group type: EXPERIMENTAL
Intervention: Duoderm CGF plus compression (Coban wrap)
Number of subjects: 30
Study 1538504 — intervention group
Group type: COMPARATOR
Intervention: Unna's boot
Number of subjects: 30
Study 6148345 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose propranolol
Number of subjects: 40
Study 31206358 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy (rosuvastatin)
Number of subjects: 683
Study 31206358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 683
Study 28852915 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal phone call recommending vaccinations
Number of subjects: 210
Study 28852915 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized mailed letter recommending vaccinations
Number of subjects: 210
Study 28852915 — intervention group
Group type: COMPARATOR
Intervention: Control group with no vaccination information
Number of subjects: 210
Study 26780033 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT booster vaccination
Number of subjects: 0
Study 26780033 — intervention group
Group type: COMPARATOR
Intervention: MenC-CRM197 booster vaccination
Number of subjects: 0
Study 24931900 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand system
Number of subjects: 100
Study 24931900 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 22157100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular dexamethasone administration after arthrocentesis
Number of subjects: 28
Study 22157100 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) administration after arthrocentesis
Number of subjects: 28
Study 19751247 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 0.5 mg once daily for 28 days
Number of subjects: 89
Study 19751247 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 1 mg once daily for 28 days
Number of subjects: 89
Study 19751247 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg once daily for 28 days
Number of subjects: 89
Study 19751247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 17921900 — intervention group
Group type: EXPERIMENTAL
Intervention: HSA-coated titanium tympanostomy tubes
Number of subjects: 149
Study 17921900 — intervention group
Group type: COMPARATOR
Intervention: Uncoated titanium tympanostomy tubes
Number of subjects: 149
Study 15611506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain education intervention (culture-specific video and booklet on pain management)
Number of subjects: 97
Study 15611506 — intervention group
Group type: COMPARATOR
Intervention: Control group (video and booklet on nutrition)
Number of subjects: 97
Study 15611506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain education intervention
Number of subjects: 97
Study 15611506 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study 11374750 — intervention group
Group type: EXPERIMENTAL
Intervention: State-induced anger
Number of subjects: 0
Study 11374750 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 9724117 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliosarcoma
Number of subjects: 18
Study 9724117 — intervention group
Group type: COMPARATOR
Intervention: GBM (entire group)
Number of subjects: 18
Study 9724117 — intervention group
Group type: COMPARATOR
Intervention: GBM (control group)
Number of subjects: 18
Study 8880102 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 ppm NO2 for 1 h with moderate intermittent exercise
Number of subjects: 22
Study 8880102 — intervention group
Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 22
Study 2124179 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel 20 mcg/day (LNg 20)
Number of subjects: 2245
Study 2124179 — intervention group
Group type: COMPARATOR
Intervention: Copper T 380Ag
Number of subjects: 2245
Study 400246 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-conducted, face-to-face progressive, deep-muscle relaxation training for 10 weekly sessions
Number of subjects: 29
Study 400246 — intervention group
Group type: COMPARATOR
Intervention: Progressive deep-muscle relaxation therapy conducted mainly by home use of audio cassettes
Number of subjects: 29
Study 400246 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific individual psychotherapy for 10 weekly sessions
Number of subjects: 29
Study 31915039 — intervention group
Group type: EXPERIMENTAL
Intervention: JIAH intervention (adolescent groups, youth leadership activities, and livelihood promotion)
Number of subjects: 40676
Study 31915039 — intervention group
Group type: COMPARATOR
Intervention: Livelihood promotion only (control group)
Number of subjects: 40676
Study 31665156 — intervention group
Group type: EXPERIMENTAL
Intervention: Resubmission process for scientific papers
Number of subjects: 288
Study 31665156 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent on reformatting
Number of subjects: 288
Study 31665156 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic burden of reformatting
Number of subjects: 288
Study 31665156 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for reform
Number of subjects: 288
Study 26158794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin alone
Number of subjects: 108
Study 26158794 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of tofogliflozin and anti-T2DM drugs
Number of subjects: 108
Study 26158794 — intervention group
Group type: COMPARATOR
Intervention: Anti-T2DM drugs alone
Number of subjects: 108
Study 26158794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 108
Study 23823042 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic hip screw (DHS) with anti-rotation screw (group 2)
Number of subjects: 65
Study 23823042 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw (DHS) alone (group 1)
Number of subjects: 65
Study 23823042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 65
Study 21413892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 9
Study 19539103 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 30 mg duloxetine
Number of subjects: 30
Study 19539103 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 60 mg duloxetine
Number of subjects: 30
Study 19539103 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 90 mg duloxetine
Number of subjects: 30
Study 19539103 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of 30 mg duloxetine (twice daily for 7 days)
Number of subjects: 30
Study 16427737 — intervention group
Group type: EXPERIMENTAL
Intervention: CRPS-affected site
Number of subjects: 18
Study 16427737 — intervention group
Group type: EXPERIMENTAL
Intervention: CRPS-affected sites
Number of subjects: 18
Study 16427737 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 18
Study 15261565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 800 mg/m2 plus methylprednisolone 1 g IV (CY/MP)
Number of subjects: 0
Study 15261565 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) once monthly for 6 months
Number of subjects: 0
Study 11385201 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv
Number of subjects: 16
Study 11385201 — intervention group
Group type: COMPARATOR
Intervention: Air-motor
Number of subjects: 16
Study 9337506 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Cue Exposure (CE)
Number of subjects: 0
Study 9337506 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavior Therapy (CBT)
Number of subjects: 0
Study 1437473 — intervention group
Group type: EXPERIMENTAL
Intervention: Two standard drifting gratings (F/F)
Number of subjects: 0
Study 1437473 — intervention group
Group type: EXPERIMENTAL
Intervention: Two non-Fourier drifting gratings (NF/NF)
Number of subjects: 0
Study 1437473 — intervention group
Group type: EXPERIMENTAL
Intervention: One standard and one non-Fourier drifting grating (F/NF)
Number of subjects: 0
Study 3896288 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine
Number of subjects: 530
Study 3896288 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 530
Study 3896288 — intervention group
Group type: EXPERIMENTAL
Intervention: First line therapy (Melphalan and Prednisone)
Number of subjects: 530
Study 3896288 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of first line therapy for a further year
Number of subjects: 530
Study 29215971 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet (MedDiet) supplemented with fish oil, received fortnightly food hampers and MedDiet cooking workshops for 3 months and fish oil supplements for 6 months
Number of subjects: 152
Study 29215971 — intervention group
Group type: COMPARATOR
Intervention: Control group attending social groups fortnightly for 3 months
Number of subjects: 152
Study 30021556 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom foot orthoses and new shoes
Number of subjects: 60
Study 30021556 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe group (sham insole with new shoes)
Number of subjects: 60
Study 26572633 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet application
Number of subjects: 34
Study 26572633 — intervention group
Group type: COMPARATOR
Intervention: Non-tourniquet application
Number of subjects: 34
Study 25126031 — intervention group
Group type: EXPERIMENTAL
Intervention: ASVAuto
Number of subjects: 18
Study 25126031 — intervention group
Group type: COMPARATOR
Intervention: bilevel-ST
Number of subjects: 18
Study 22173041 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mild home exercises (calisthenics focusing on balance-control, low-back-connected musculature) for 15 minutes daily over 2 months
Number of subjects: 30
Study 22173041 — intervention group
Group type: COMPARATOR
Intervention: Matched control group observed and examined only
Number of subjects: 30
Study 20202636 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg Mycophenolate mofetil (MMF) BD for at least 2 weeks
Number of subjects: 21
Study 20202636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 17921409 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea drinkers
Number of subjects: 1500
Study 17921409 — intervention group
Group type: COMPARATOR
Intervention: Non-tea drinkers
Number of subjects: 1500
Study 15806748 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study 15806748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12232562 — intervention group
Group type: EXPERIMENTAL
Intervention: Venoruton (HR) 2 g/day for 8 weeks
Number of subjects: 90
Study 12232562 — intervention group
Group type: COMPARATOR
Intervention: Daflon (500 mg) three tablets daily every 8 hours
Number of subjects: 90
Study 10091293 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (5000 U anti-Xa; Fragmin P forte) s.c.
Number of subjects: 200
Study 10091293 — intervention group
Group type: COMPARATOR
Intervention: Dose-adjusted coumarin (Marcumar) p.o.
Number of subjects: 200
Study 8526279 — intervention group
Group type: COMPARATOR
Intervention: 5-pound test for control subjects
Number of subjects: 116
Study 8526279 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-pound test for affected knees
Number of subjects: 116
Study 8526279 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic determinant for peripatellar imbalance
Number of subjects: 116
Study 2047886 — intervention group
Group type: EXPERIMENTAL
Intervention: Close prospective, long-term follow-up of PSC patients
Number of subjects: 0
Study 2047886 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical survival modeling
Number of subjects: 0
Study 7471600 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg, 100 mg, 200 mg
Number of subjects: 0
Study 7471600 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 50 mg, 100 mg, 200 mg
Number of subjects: 0
Study 7471600 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 400 mg
Number of subjects: 0
Study 7471600 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 50 mg, 100 mg, 200 mg
Number of subjects: 0
Study 7471600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30554135 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART-CPT (CogSMART+CPT)
Number of subjects: 100
Study 30554135 — intervention group
Group type: COMPARATOR
Intervention: CPT (Cognitive Processing Therapy)
Number of subjects: 100
Study 27888578 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraBLOX™ radiation attenuating hand cream
Number of subjects: 2
Study 27888578 — intervention group
Group type: COMPARATOR
Intervention: Unshielded dosimeter (control)
Number of subjects: 2
Study 26549399 — intervention group
Group type: EXPERIMENTAL
Intervention: SX-1001 (low-intensity pulsed ultrasound device)
Number of subjects: 44
Study 26549399 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study 24119605 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone (TA) 20 mg-soaked bioabsorbable dressing
Number of subjects: 20
Study 24119605 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline-impregnated dressing)
Number of subjects: 20
Study 21282685 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant with DMAE‐CB (1% by weight)
Number of subjects: 3
Study 21282685 — intervention group
Group type: COMPARATOR
Intervention: Negative control sealant (Helioseal without DMAE‐CB)
Number of subjects: 3
Study 21282685 — intervention group
Group type: COMPARATOR
Intervention: Positive control sealant (Helioseal F with fluoride-releasing resin)
Number of subjects: 3
Study 19634512 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron(III) hydroxide polymaltose complex (IPC, Maltofer) containing 100 mg of elemental iron, 6 days a week for 8 months
Number of subjects: 4
Study 19634512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 19634512 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron(III) hydroxide polymaltose complex (IPC, Maltofer)
Number of subjects: 4
Study 17602935 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1106
Study 17602935 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate
Number of subjects: 1106
Study 17602935 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate (BMI >30 kg/m2)
Number of subjects: 1106
Study 17602935 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate (BMI >40 kg/m2)
Number of subjects: 1106
Study 15046728 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (anticholinesterase)
Number of subjects: 0
Study 11133598 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLHb (1 g/kg)
Number of subjects: 26
Study 11133598 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLHb (936 +/- 276 mg/kg)
Number of subjects: 26
Study 11133598 — intervention group
Group type: COMPARATOR
Intervention: Packed red blood cells
Number of subjects: 26
Study 9926153 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose allergen exposure (individualised to 25% of the total dose causing immediate and late response)
Number of subjects: 8
Study 9926153 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose allergen exposure
Number of subjects: 8
Study 9926153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Curity tape without pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukopor tape without pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpore tape without pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Curity tape with mastisol pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukopor tape with mastisol pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpore tape with mastisol pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Curity tape with benzoin pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukopor tape with benzoin pretreatment
Number of subjects: 2
Study 7923524 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpore tape with benzoin pretreatment
Number of subjects: 2
Study 2452146 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 Gy/18 fractions/4 1/2 weeks (arm 1)
Number of subjects: 273
Study 2452146 — intervention group
Group type: COMPARATOR
Intervention: 31.2 Gy/4 fractions/4 weeks (arm 2)
Number of subjects: 273
Study 2452146 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 273
Study 31729990 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 7637
Study 31729990 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 7637
Study 31729990 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia
Number of subjects: 7637
Study 31729990 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior heart failure
Number of subjects: 7637
Study 28027334 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim‐sulfamethoxazole
Number of subjects: 607
Study 28027334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607
Study 25391326 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multidisciplinary prevention program
Number of subjects: 0
Study 25391326 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0